Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nsclc testing braf nu | 0.85 | 0.3 | 8714 | 65 | 21 |
nsclc | 0.39 | 1 | 7216 | 36 | 5 |
testing | 0.25 | 0.6 | 2410 | 84 | 7 |
braf | 1.67 | 0.9 | 1951 | 30 | 4 |
nu | 0.73 | 0.1 | 4232 | 57 | 2 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nsclc testing braf nu | 0.07 | 0.6 | 7357 | 99 |
biomarker testing for nsclc | 1.37 | 0.1 | 8459 | 25 |
nsclc randomised study diagnostic biomarker | 0.45 | 0.6 | 4443 | 100 |
nccn guidelines biomarker testing | 0.87 | 0.4 | 9579 | 58 |
nccn guidelines molecular testing nsclc | 1.3 | 0.3 | 6705 | 98 |
biomarker testing in canada | 1.42 | 0.8 | 6390 | 32 |
biomarker testing for cancer patients | 0.12 | 0.3 | 5125 | 48 |
biomarker testing for cancer treatment | 0.43 | 0.1 | 376 | 14 |
biomarker testing for cancer | 1.23 | 0.2 | 603 | 21 |
biomarker exploration for solid tumors | 0.32 | 1 | 4325 | 56 |
how is nsclc diagnosed | 1.37 | 0.1 | 2074 | 18 |
alk-positive nsclc | 1.12 | 0.4 | 7516 | 55 |
clinical trials for nsclc | 1.32 | 0.4 | 7866 | 8 |